The discovery of a new drug candidate is just the start of the complex multidisciplinary pathway through preclinical development to reach a successful first clinical trial application. At this early stage in a product’s life the failure rate is high and costs can spiral as unforeseen hurdles arise.
Few people have the expertise to manage the multiple interdependent tasks that comprise preclinical and non-clinical drug development. Even fewer have the necessary regulatory knowledge and experience. And yet, all of these skills and expertise are essential to ensure successful project advancement.
ELLIPTICAL PRECLINICAL DEV. DIAGRAM